Anipryl (selegiline hydrochloride tablets) is indicated for the control of clinical signs associated with canine cognitive dysfunction syndrome (CDS) and control of clinical signs associated with uncomplicated canine pituitary dependent hyperadrenocorticism (PDH).

2025年3月2日 · Anipryl tablets are indicated for the control of clinical signs associated with canine cognitive dysfunction syndrome (CDS) and control of clinical signs associated with …

Selegiline (brand names: Anipryl®, Eldepryl®, l-deprenyl, Selgian®, Zelapar®) is a monoamine oxidase inhibitor (MAOI) used to treat signs due to cognitive dysfunction syndrome in dogs and cats. It has also been used to treat pituitary dependent Cushing’s disease, although its effectiveness has not been proven.

Anipryl is an oral tablet prescribed by veterinarians to control the clinical signs associated with canine Cognitive Dysfunction syndrome (CDS) and uncomplicated canine pituitary-dependent hyperadrenocorticism (PDH).

2001年1月1日 · There are two approved indications for Selegiline Hydrochloride in dogs: treating pituitary-dependent Cushing’s disease, an excess in corticosteroid hormone production stemming from a pituitary tumor, and treating senile mental deterioration (canine cognitive dysfunction).

2025年2月11日 · Key takeaways: Selegiline (Anipryl) is most often used to treat canine cognitive dysfunction. But it can also be used to treat Cushing’s disease in dogs. Selegiline is well tolerated by most dogs, with a low risk of side effects. Typical side …

2022年12月13日 · Anipryl tablets are indicated for the control of clinical signs associated with canine cognitive dysfunction syndrome (CDS) and control of clinical signs associated with uncomplicated canine pituitary dependent hyperadrenocorticism (PDH).

2023年3月21日 · Selegiline hydrochloride is classified as a monoamine oxidase inhibitor (MAOI). It blocks the reabsorption of beneficial nerve transmitters such as dopamine and serotonin, …

Anipryl is an FDA-approved drug to treat CDS and Cushing's disease, also known as Pituitary Dependent Hyperadrenocorticism (PDH). These two conditions can develop in elderly dogs by affecting the brain and its chemicals, but may also affect middle-aged dogs as well.